Fucoidan from Laminaria cichorioides inhibits AP-1 transactivation and cell transformation in the mouse epidermal JB6 cells

Molecular Carcinogenesis

Volumn 47, Issue 8, 2008, Pages 629-637

  Na, Yeon Lee ^a   Ermakova, Svetlana P ^b   Choi, Hoo Kyun ^a   Kusaykin, Michail I ^b   Shevchenko, Natalya M ^b   Zvyagintseva, Tatyana N ^b   Choi, Hong Seok ^a  

^a Chosun University   (South Korea)

^b PACIFIC INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

AP 1; c fos; c jun; Cell transformation; EGFR; Fucoidan

Indexed keywords

CELL SURFACE RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FUCOIDIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHORBOL 13 ACETATE 12 MYRISTATE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING ASSAY; CELL TRANSFORMATION; CYTOTOXICITY; EPIDERMIS CELL; IN VITRO STUDY; LAMINARIA; MOUSE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR CELL;

ANIMALS; CELL ADHESION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; EPIDERMAL GROWTH FACTOR; EPIDERMIS; LAMINARIA; MAP KINASE SIGNALING SYSTEM; MICE; PHOSPHORYLATION; POLYSACCHARIDES; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1;

LAMINARIA CICHORIOIDES;

EID: 48149084449     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20428     Document Type: Article

References (52)

1. Painter T. Algal polysaccharides. The polysaccharides, Vol. 2. New York: Academic Press; 1983. pp. 195-285.
2. Percival E. Chemistry and enzymology of marine algae polysaccharides. New York: Academic Press; 1967. pp. 53-71.
3. Duarte ME, Cardoso MA, Noseda MD, Cerezo AS. Structural studies on fucoidans from the brown seaweed Sargassum stenophyllum. Carbohydr Res 2001;333:281-293.
4. Durig J, Bruhn T, Zurborn KH, Gutensohn K, Bruhn HD, Beress L. Anticoagulant fucoidan fractions from Fucus vesiculosus induce platelet activation in vitro. Thromb Res 1997;85:479-491.
5. Patankar MS, Oehninger S, Barnett T, Williams RL, Clark GF. A revised structure for fucoidan may explain some of its biological activities. J Biol Chem 1993;268:21770-21776.
6. Chevolot L, Mulloy B, Ratiskol J, Foucault A, Colliec-Jouault S. A disaccharide repeat unit is the major structure in fucoidans from two species of brown algae. Carbohydr Res 2001;330:529-535.
7. Soeda S, Kozako T, Iwata K, Shimeno H. Oversulfated fucoidan inhibits the basic fibroblast growth factor-induced tube formation by human umbilical vein endothelial cells: Its possible mechanism of action. Biochim Biophys Acta 2000;1497:127-134.
8. Riou D, Colliec-Jouault S, Pinczon du Sel D, et al. Antitumor and antiproliferative effects of a fucan extracted from ascophyllum nodosum against a non-small-cell bronchopulmonary carcinoma line. Anticancer Res 1996;16:1213-1218.
9. Itoh H, Noda H, Amano H, Zhuaug C, Mizuno T, Ito H. Antitumor activity and immunological properties of marine algal polysaccharides, especially fucoidan, prepared from Sargassum thunbergii of Phaeophyceae. Anticancer Res 1993;13:2045-2052.
10. Zhuang C, Itoh H, Mizuno T, Ito H. Antitumor active fucoidan from the brown seaweed, umitoranoo (Sargassum thunbergii). Biosci Biotechnol Biochem 1995;59:563-567.
11. Koyanagi S, Tanigawa N, Nakagawa H, Soeda S, Shimeno H. Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol 2003;65:173-179.
12. Frenette PS, Weiss L. Sulfated glycans induce rapid hematopoietic progenitor cell mobilization: Evidence for selectin-dependent and independent mechanisms. Blood 2000;96:2460-2468.
13. Sweeney EA, Lortat-Jacob H, Priestley GV, Nakamoto B, Papayannopoulou T. Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: Involvement in mobilization of stem/progenitor cells. Blood 2002;99:44-51.
14. Shibata H, Iimuro M, Uchiya N, et al. Preventive effects of Cladosiphon fucoidan against Helicobacter pylori infection in Mongolian gerbils. Helicobacter 2003;8:59-65.
15. Dong Z, Birrer MJ, Watts RG, Matrisian LM, Colburn NH. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sci USA 1994;91:609-613.
16. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991;1072:129-157.
17. Hunter T, Karin M. The regulation of transcription by phosphorylation. Cell 1992;70:375-387
18. Chen WS, Lazar CS, Poenie M, Tsien RY, Gill GN, Rosenfeld MG. Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor. Nature 1987;328:820-823.
19. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001;2:127-137.
20. Humphrey PA, Wong AJ, Vogelstein B, et al. Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc Natl Acad Sci USA 1990;87:4207-4211.
21. Gorgoulis V, Aninos D, Mikou P, et al. Expression of EGF, TGF-alpha and EGFR in squamous cell lung carcinomas. Anticancer Res 1992;12:1183-1137.
22. Sizeland AM, Burgess AW. Anti-sense transforming growth factor alpha oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell line. Mol Biol Cell 1992;3:1235-1243.
23. Riese DJ, II., Stern DF. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 1998;20:41-48.
24. Amos S, Martin PM, Polar GA, Parsons SJ, Hussaini IM. Phorbol 12-myristate 13-acetate induces eoidermal growth factor receptor transactivation via protein kinase Cdelta/c-Src pathways in glioblastoma cells. J Biol Chem 2005;280:7729-7738.
25. Zvyagintseva TN, Shevchenko NM, Popivnich IB, et al. A new procedure for the separation of water-soluble polysaccharides from brown seaweeds. Carbohydr Res 1999;322:32-39.
26. Dubois M, Gilles K, Hamilton J, Robets P, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956;28:350-356
27. Nelson TE. A photometric adaptation of the Somogy method for determination of glucose. J Biol Chen 1944;153:375-381.
28. Colburn NH, Wendel EJ, Abruzzo G. Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: Mitogen-resistant variants are sensitive to promotion. Proc Natl Acad Sci USA 1981;73:6912-6916.
29. Zvyagintseva TN, Shevchenko NM, Nazarenko EL, et al. Water-soluble polysaccharides of some brown algae of the Russian Far-East. Structure and biological action of low-molecular mass polyuronans. J Exp Mar Bio Ecol 2005;320:123-131.
30. Zvyagintseva TN, Shevchenko NM, Nazarenko EL, et al. Water-soluble polysaccharides of some far-eastern brown seaweeds. Distribution, structure, and their dependence on the developmental conditions. J Exp Mar Biol Ecol 2003;294:1-13.
31. Bode AM, Dong Z. Mitogen-activated protein kinase activation in UV-induced signal transduction. Sci STKE 2003;2003:RE2.
32. Clarke N, Arenzana N, Hai T, Minden A, Prywes R. Epidermal growth factor induction of the c-jun promoter by a Rac pathway. Mol Cell Biol 1998;18:1065-1073.
33. Gupta P, Prywes R. ATF1 phosphorylation Dy the ERK MAPK pathway is required for epidermal growth factor-induced c-jun expression. J Biol Chem 2002;277:50550-50556.
34. Herschman HR. Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem 1991;60:281-319.
35. Curran T, Franza BR Jr. Fos and Jun: The AP-1 connection. Cell 1988;55:395-397.
36. Tyagi A, Agarwal R, Agarwal C. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU14B cells: Possible role in antiproliferation and apoptosis. Oncogene 2003;22:1302-1316.
37. Dong Z, Cmarik JL. Harvesting cells under anchorage-independent cell transformation conditions for biochemical analyses. Sci STKE 2002;2002:PL7.
38. Berteau O, Mulloy B. Sulfated fucans, fresh perspectives: Structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. Glycobiology 2003;13:29R-40R.
39. Vallone D, Battista S, Pierantoni GM, et al. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J 1997;16:5310-5321.
40. Domann FE Jr, Levy JP, Finch JS, Bowden GT. Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells. Mol Carcinog 1994;9:61-66.
41. Yuspa SH. The pathogenesis of squamous cell cancer: Lessons learned from studies of skin carcinogenesis. J Dermatol Sci 1998;17:1-7.
42. Barthelman M, Chen W, Gensler HL, Huang C, Dong Z, Bowden GT. Inhibitory effects of perillyl alcohol on UVB-induced murine skin cancer and AP-1 transactivation. Cancer Res 1998;58:711-716.
43. Dong Z, Crawford HC, Lavrovsky V, et al. A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes. Mol Carcinog 1997;19:204-212.
44. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995;270:16483-16486.
45. Dong Z, Ma W, Huang C, Yang CS. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res 1997;57:4414-4419.
46. Huang C, Li J, Ma WY, Dong Z. JNK activation is required for JB6 cell transformation induced by tumor necrosis factor-alpha but not by 12-O-tetradecanoylphorbol-13-acetate. J Biol Chem 1999;274:29672-29676.
47. Chen N, Nomura M, She QB, et al. Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice. Cancer Res 2001;61:3908-3912.
48. Wells A. EGF receptor. Int J Biochem Cell Biol 1999;31:637-643.
49. Gschwind A, Zwick E, Prenzel N, Leserer M, Ullrich A. Cell communication networks: Epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 2001;20:1594-1600.
50. Ciardiello F. Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents. Drugs 2000;60:25-32; discussion 41-22.
51. Mendelsohn J, Baselga J. The EGF receptor family as targets for cancer therapy. Oncogene 2000;19:6550-6565.
52. Kong AN, Yu R, Hebbar V, et al. Signal transduction events elicited by cancer prevention compounds. Mutat Res 2001;480-481:231-241.